Prove efficacy of Itolizumab for subcutaneous route: CDSCO panel Tells Biocon Biologics Dr. Divya Colin13 Sept 2023 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has opined the drug major Biocon...
Health Bulletin 13/September/2023 Roshni Dhar13 Sept 2023 5:02 PM ISTHere are the top health stories for the day:MBBS students and professors respond to altered passing marks: Pass rate drops, competition risesThe...
Generate Phase II Clinical Data on 20 Indian subjects for dose selection: CDSCO panel Tells Pfizer on Ritlecitinib Dr. Divya Colin10 Sept 2023 6:00 PM ISTNew Delhi: Noting that in the presented Phase II clinical trial data, no Indian subjects were involved and the study disease is very heterogeneous,...
MSN Lab gets CDSCO Panel Nod To Manufacture, Market Combi kit for Macitentan 10mg plus Tadalafil 20mg Dr. Divya Colin9 Sept 2023 6:00 PM ISTNew Delhi: Granting approval for Phase III clinical trial and bioequivalence (BE) study wavier, the Subject Expert Committee (SEC) functional under...
CDSCO raises alert on fake Adcetris injection manufactured by Takeda Pharma Roshni Dhar9 Sept 2023 12:32 PM ISTConcerning falsified versions of Adcetris Injection (Brentuximab Vedotin) manufactured by Takeda Pharmaceutical, the Central Drugs Standard Control...
CDSCO raises alert on fake Lymphoma drug Adcetris Injection manufactured by Takeda Pharma Dr. Divya Colin8 Sept 2023 6:00 PM ISTNew Delhi: Concerning falsified versions of Adcetris Injection (Brentuximab Vedotin) manufactured by Takeda Pharmaceutical, the Central Drugs Standard...
Health Bulletin 08/September/2023 Roshni Dhar8 Sept 2023 5:35 PM ISTHere are the top health stories for the day:NMC streamlines medical admissions: State counselling committees to now enter data on available seats, not...
52 percent Indian families have had 1 member face unknown side effects from medicine: Report MD Bureau8 Sept 2023 1:45 PM ISTNew Delhi: A whopping 52 per cent Indian families have had at least one member face unknown side effects from medicine, according to a report on...
DCGI flags popular antacid Digene Gel, Abbott initiates recall Farhat Nasim6 Sept 2023 7:25 PM ISTNew Delhi: The popular antacid Digene gel has received a warning alert from the Drugs Control General of India (DCGI) following which batches of the...
Lupin Gets CDSCO Panel Nod To Manufacture, Market FDC of Glycopyrronium, Vilanterol Inhalation Powder Dr. Divya Colin5 Sept 2023 6:00 PM ISTNew Delhi: The drug major Lupin has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Submit Supportive Documents for safety of Fluticasone dose: CDSCO panel Tells Glenmark on FDC pulmonary drug Dr. Divya Colin4 Sept 2023 6:00 PM ISTNew Delhi: Based on the Phase III clinical trial protocol and justification for the inhalation toxicity of the fixed-dose combination (FDC) pulmonary...
CDSCO nod to Synokem Pharma for marketing, manufacturing antidiabetic FDC Pioglitazone, Vildagliptin Isra Zaman4 Sept 2023 2:21 PM ISTWith the condition of conducting phase IV clinical trial, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
